생화학분자생물학회입니다.
The roles and mechanisms of coding and noncoding RNA variations in cancer
작성자
Suk Woo Nam작성일자
2024-12-26조회수
382![]() |
Suk Woo Nam ( swnam@catholic.ac.kr ) | |
2003-present | Professor, Department of Pathology, The Catholic University of Korea, Republic of Korea | |
2014-present | Director, Functional RNA Research Center, The Catholic University of Korea, Republic of Korea | |
2001-2002 | Research Associate, Genome Institute of Singapore, Singapore | |
1997-2001 | Post-doctoral fellow, Lab of Pathology, National Cancer Institute, National Institute of Health, Bethesda, MD, USA | |
1991-1997 | Ph.D. Pharmacist, Sungkyunkwan University, College of Pharmacy, Seoul, Republic of Korea |
The roles and mechanisms of coding and noncoding RNA variations in cancer
Functional variations in coding and noncoding RNAs are crucial in tumorigenesis, with cancer-specific alterations often resulting from chemical modifications and posttranscriptional processes mediated by enzymes. These RNA variations have been linked to tumor cell proliferation, growth, metastasis, and drug resistance and are valuable for identifying diagnostic or prognostic cancer biomarkers. The diversity of posttranscriptional RNA modifications, such as splicing, polyadenylation, methylation, and editing, is particularly significant due to their prevalence and impact on cancer progression. Additionally, other modifications, including RNA acetylation, circularization, miRNA isomerization, and pseudouridination, are recognized as key contributors to cancer development. Understanding the mechanisms underlying these RNA modifications in cancer can enhance our knowledge of cancer biology and facilitate the development of innovative therapeutic strategies. Targeting these RNA modifications and their regulatory enzymes may pave the way for novel RNA-based therapies, enabling tailored interventions for specific cancer subtypes. This review provides a comprehensive overview of the roles and mechanisms of various coding and noncoding RNA modifications in cancer progression and highlights recent advancements in RNA-based therapeutic applications.
Exp Mol Med. 2024 Sep;56(9):1909-1920. doi: 10.1038/s12276-024-01307-x
https://pubmed.ncbi.nlm.nih.gov/39218979/